BioSpace News Archive

Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2023 and provided an update on the Company’s operations.

Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced it will report its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023.

Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) and Dianthus Therapeutics, Inc. (“Dianthus”), a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced financial results for the first quarter ended March 31, 2023 and highlighted recent corporate developments.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:00 p.m., U.S. eastern time on May 4, 2023 in New York, NY.

Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2023.

KaliVir Immunotherapeutics, Inc. today announced that its Director of Immunology, Ravikumar Muthuswamy , Ph.D., will present " Novel Oncolytic therapy VET3-TGI restricts TGFβ1 and augments Type-1 immune response in TME, in an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting.

Ginkgo Bioworks today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2023.

Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart’s Sunriser© Capsule-based Dry Powder Inhaler platform.

Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors.